Companies
Employees11-50
Funding$5.75M
Valuation$15M - $22M
Revenue$0.5M
3 active roles
Healthcare AIAI ApplicationB2B SaaSSeed$1M-$10M
About
Sable Bio provides an AI-powered platform for drug target safety intelligence, helping pharmaceutical and biotech companies predict toxicity risks early in the development process. The platform leverages LLMs and causal inference to analyze multimodal biomedical data from clinical, genetic, and literature sources. The company generates revenue through B2B subscriptions and licenses for its predictive safety tools.
Active Roles
3Key Investors
MMC Ventures, Episode 1 Ventures, Seedcamp